PF-06835375 clinical trials

Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

This study is testing a new medicine called PF-06835375 for adults with a blood condition called Immune Thrombocytopenia (ITP). It aims to see if the medicine is safe and helps increase blood platelet counts in people who have had ITP for a few months or longer.